Leerink Partnrs Cuts Earnings Estimates for Encompass Health

Encompass Health Co. (NYSE:EHC) – Research analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Encompass Health in a research note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings per share of $1.18 for the quarter, down from their prior forecast of $1.23. The consensus estimate for Encompass Health’s current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Encompass Health’s Q2 2026 earnings at $1.20 EPS, FY2027 earnings at $5.23 EPS and FY2028 earnings at $5.43 EPS.

A number of other research analysts have also commented on the company. StockNews.com lowered Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday, February 7th. Truist Financial restated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Royal Bank of Canada restated an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a research report on Tuesday. KeyCorp raised their price target on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday. Finally, Barclays raised their price target on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. One analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, Encompass Health currently has an average rating of “Buy” and an average target price of $107.67.

Encompass Health Stock Up 2.1 %

Shares of EHC opened at $100.10 on Thursday. The firm has a market capitalization of $10.08 billion, a price-to-earnings ratio of 22.44, a PEG ratio of 1.18 and a beta of 0.90. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The business’s fifty day moving average price is $96.00 and its two-hundred day moving average price is $95.46. Encompass Health has a 52 week low of $72.57 and a 52 week high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in EHC. MassMutual Private Wealth & Trust FSB raised its stake in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the period. UMB Bank n.a. raised its stake in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the period. V Square Quantitative Management LLC raised its stake in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares during the period. Avior Wealth Management LLC acquired a new stake in shares of Encompass Health in the 3rd quarter valued at about $40,000. Finally, CBIZ Investment Advisory Services LLC raised its stake in shares of Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after purchasing an additional 127 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 2.10% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.